Relmada Therapeutics logo
Relmada Therapeutics
RLMD | NASDAQ
Chart Builder DCF Calculator
$3.61
-$0.60 (-14.25%)
At close: Nov 16, 2026, 4:00 PM ET
$3.60
-$0.01 (-0.28%)
Pre-market: Nov 17, 2026, 4:54 AM ET

Relmada Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-13.86M -12.91M -19.05M -19.87M -10.09M -9.87M -17.56M -18.66M -21.73M -17.77M -21.83M -25.17M -22M -25.3M -26.32M -37.94M -39.42M -39.93M -39.75M -34.38M -42.61M -26.55M -22.22M
– – – – – – – 19.08M 23.01M 18.82M – 26.83M – – – 315 315 315 315 – – 452 806
1.02M -1.77M 3.63M 3.21M 3.61M 3.47M 4.48M 6.72M 7.96M 7.21M 8.3M 9.89M 11.39M 11.17M 11.35M 11.63M 8.34M 12.3M 11.93M 18.36M 8.01M 8.27M 5.85M
-2.37M 1.78M -1.96M 1.12M 4.63M -71.99K -1.9M 1.12M -636.69K -1.61M -1.08M 4.78M 343.99K -211.12K -586.04K -4.24M -481.01K 8.22M 7.11M -10.26M 911.39K -1.73M 292.1K
2.5M 4.22M 549.96K 827.11K -4.96M -33.41K -218.68K -18.84M -23.44M -18.91M -103.85K -27.23M 630.86K 639.63K -624.4K -6M 7.86M -5.19M 1.78M -9.89M 10.49M 412.87K 229.95K
– – – – – – – – – – – – – – – – – – – – – – –
-2.24M 858.8K -199.33K 1.23M 4.72M 24.91K -4.77M 2.9M -2.47M -2.62M 599.76K 5.43M -1.65M 220.53K -913.58K -3.57M -3.65M 11.2M 6.61M -11.76M 3.18M 658.83K 47.66K
-12.59M -9.61M -15.07M -14.6M -6.72M -6.4M -18.07M -8.8M -16.66M -13.26M -13.04M -10.25M -11.63M -13.27M -16.51M -35.88M -26.86M -21.63M -19.43M -37.66M -20.92M -17.21M -16.09M
– – – – – – – – – – – 4 – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
-24.88M -24.75M -149.52M -82.79M -233.93K -321.46K -487.92K -654.64K -3.11M -1.3M -7.01M -33.31M -11.57M -10.81M -34.77M -8.3M -5.58M -7.5M -25.92M -140.51M -25.6M -36.21M -20.66M
31.84M 42.34M 14.29M 5.86M 6.99M 7M 15.85M 12M 19.26M 15.31M 17.07M 41.05M 15.43M 9.66M 74.77M 6.65M 37.14M 7.36M 15.89M 49.32M 53.12M 30.3M 36.13M
– – – – – – – – – – – – – – – – – – – – – – –
6.95M 17.59M -135.23M -76.93M 6.75M 6.68M 15.36M 11.35M 16.14M 14.01M 10.06M 7.74M 3.86M -1.15M 40M -1.66M 31.56M -140.52K -10.03M -91.18M 27.51M -5.91M 15.47M
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– -9.88M -65.65K – – -73.02K – -172.49K -89.6K – -25K -98.46K – – – 373.63K -134.63K 948.09K 364.81K 511.09K 175.01K 481.45K 1.46M
17.75K -6.42M 156.57M 93.64M – -73.02K – -172.49K -89.6K – 221.75K -98.46K – – – 409.88K 569.09K 14.09M 29.95M 161.84M 185.16K 23.99M 1.93M
-5.61M 1.56M 6.28M 2.11M 31.13K 203.65K -2.71M 2.37M -602.47K 751.24K -2.76M -2.61M -7.77M -14.43M 23.5M -37.13M 5.26M -7.67M 490.94K 32.99M 6.78M 865.3K 1.31M
-12.59M -9.61M -15.07M -14.6M -6.72M -6.4M -18.07M -8.8M -16.66M -13.26M -13.04M -10.25M -11.63M -13.27M -16.51M -35.88M -26.86M -21.63M -19.43M -37.66M -20.92M -17.21M -16.09M
-13.61M -7.83M -18.7M -17.81M -10.33M -9.87M -22.55M -15.52M -24.62M -20.48M -21.33M -20.14M -23.02M -24.44M -27.86M -47.51M -35.21M -33.92M -31.36M -56.02M -28.93M -25.48M -21.94M
– – – – – – – – – – – -4 – – – – – – – – – – –
– – – – – – – – – – – 8 – – – – – – – – – – –
-12.59M -9.61M -15.07M -14.6M -6.72M -6.4M -18.07M -8.8M -16.66M -13.26M -13.04M -10.25M -11.63M -13.27M -16.51M -35.88M -26.86M -21.63M -19.43M -37.66M -20.92M -17.21M -16.09M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.